The recent election results will usher in sweeping changes for major federal health care policies, programs, and the courts.

A recent rulemaking regarding patient care decision support tools is an important step forward in ensuring safety and equity ...

Ultimately, while employers search for ways to lower health plan spending on prescription drugs, they should consider the ...

Adding pharmacists to primary care practices increases the primary care workforce because pharmacists can provide many ...

With a clean sweep of the White House and Congress likely, and a favorably disposed federal judiciary, Republicans are poised ...

The current US Supreme Court has no fundamental understanding of a range of medical, engineering, technological, or ...

School-entry immunization requirements play an important role in preventing diseases and in protecting public health. 1, 2 Such policies have a long-standing precedent in the United States, dating ...

Christopher S. Brunt, Georgia Southern University, Statesboro, Georgia. John R. Bowblis ([email protected]), Miami University, Oxford, Ohio. Robert Applebaum, Miami ...

Health Insurance Gary Claxton and coauthors report the results of the twenty-sixth annual KFF Employer Health Benefits Survey, fielded in the first half of 2024. Among their many findings are that ...

The United States has some of the poorest health outcomes among high-income countries around the world, outcomes that are particularly striking for racial and ethnic minority groups and rural ...

Increasingly, states are adopting Section 1115 waivers that allow Medicaid to address health-related social needs (HRSN) such as food insecurity, housing instability, and lack of transportation.

Health Affairs' Editor-in-Chief Alan Weil interviews Janice Jhang of Harvard University about her recent paper that explores how regulatory and market forces are driving adoption of biosimilars.